Page 95 - Read Online

Della Corte et al. Hepatoma Res 2022;8:5 https://dx.doi.org/10.20517/2394-5079.2021.103 Page 15 of 15

cholangiocarcinoma. Ann Surg Oncol 2020;27:3729-37. DOI PubMed
84. Brown DB, Cardella JF, Sacks D, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization,
and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006;17:225-32. DOI PubMed
85. Kasai K, Kooka Y, Suzuki Y, et al. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated
interferon α-2b for advanced intrahepatic cholangiocarcinoma. Ann Surg Oncol 2014;21:3638-45. DOI PubMed
86. Cantore M, Mambrini A, Fiorentini G, et al. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil
in patients with unresectable biliary tract tumors. Cancer 2005;103:1402-7. DOI PubMed
87. Cai Z, He C, Zhao C, Lin X. Survival comparisons of hepatic arterial infusion chemotherapy with mFOLFOX and transarterial
chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma. Front Oncol 2021;11:611118. DOI PubMed PMC
88. Hughes MS, Zager J, Faries M, et al. Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion
compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol 2016;23:1309-19. DOI PubMed
PMC
89. Marquardt S, Kirstein MM, Brüning R, et al. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with
intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Eur Radiol 2019;29:1882-92.
DOI PubMed
90. Koch C, Franzke C, Bechstein WO, et al. Poor prognosis of advanced cholangiocarcinoma: real-world data from a tertiary referral
center. Digestion 2020;101:458-65. DOI PubMed
91. Mosconi C, Gramenzi A, Ascanio S, et al. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a
survival, efficacy and safety study. Br J Cancer 2016;115:297-302. DOI PubMed PMC
92. Edeline J, Touchefeu Y, Guiu B, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic
cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 2020;6:51-9. DOI PubMed PMC
93. Valle J, Wasan H, Palmer DH, et al; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract
cancer. N Engl J Med 2010;362:1273-81. DOI PubMed
94. Lamarca A, Ross P, Wasan HS, et al. Advanced intrahepatic cholangiocarcinoma: post hoc analysis of the ABC-01, -02, and -03
clinical trials. J Natl Cancer Inst 2020;112:200-10. DOI PubMed
95. Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine
and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 2020;6:60-7. DOI
PubMed PMC